中國燃氣(00384.HK)與三峽投資戰略合作 拓新能源項目
中國燃氣(00384.HK)公佈,與長江三峽投資訂立戰略合作協議,公司擬認購三峽投資設立的投資基金,並利用公司在全國各地的項目公司,以及結合三峽投資的資金、技術以及行業經驗,優先在集團項目公司所在地開展分佈式可再生能源領域的合作。
雙方亦會共同調研並制定目標城市綠色綜合能源管理、低碳轉型發展規劃及行動實施方案,並擬選擇「十堰零碳汽車城」作爲合作示範項目,積極引入綠色水電,投資光伏、風電、源網荷儲一體化等新能源項目,以及共同參與氫能源全產業鏈的技術研究、商業應用和項目開發,重點針對長江大保護的清潔能源解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.